Cargando…

A Brief Look at Hashimoto’s Disease, Adrenal Incidentalomas, Obesity and Insulin Resistance—Could Endocrine Disruptors Be the Other Side of the Same Coin?

Hashimoto’s disease (HD) is the most common cause of hypothyroidism in developed countries. The exact pathomechanism behind it has not been clearly established; however, an interplay of genetic susceptibility, environmental triggers (including diet) and epigenetic factors seems to be involved. Among...

Descripción completa

Detalles Bibliográficos
Autores principales: Gontarz-Nowak, Katarzyna, Szklarz, Michał, Szychlińska, Magdalena, Matuszewski, Wojciech, Bandurska-Stankiewicz, Elżbieta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385892/
https://www.ncbi.nlm.nih.gov/pubmed/37512046
http://dx.doi.org/10.3390/medicina59071234
_version_ 1785081525404958720
author Gontarz-Nowak, Katarzyna
Szklarz, Michał
Szychlińska, Magdalena
Matuszewski, Wojciech
Bandurska-Stankiewicz, Elżbieta
author_facet Gontarz-Nowak, Katarzyna
Szklarz, Michał
Szychlińska, Magdalena
Matuszewski, Wojciech
Bandurska-Stankiewicz, Elżbieta
author_sort Gontarz-Nowak, Katarzyna
collection PubMed
description Hashimoto’s disease (HD) is the most common cause of hypothyroidism in developed countries. The exact pathomechanism behind it has not been clearly established; however, an interplay of genetic susceptibility, environmental triggers (including diet) and epigenetic factors seems to be involved. Among the latter, increasingly more attention has been paid to some hormonally active substances, known as endocrine disruptors, which are commonly used worldwide. HD has become a condition widely reported in the media, acting as a culprit for inexplicable weight gain, chronic fatigue or weakness. Nevertheless, the recognition of HD is undeniably increasing and represents a major public health burden. At the same time, improving access to imaging tests has increased the number of incidentally diagnosed adrenal tumors. Above all, the widespread use of chest computed tomography (CT) due to the COVID-19 pandemic has contributed to frequent incidental detection of adrenal lesions. Fortunately, a vast majority of these findings are asymptomatic benign tumors with no excessive hormonal activity, and therefore, they are defined as adrenal incidentalomas (AIs). Interestingly, recent studies have indicated that patients with AIs are more prone to obesity and insulin resistance. Although mutual relationships between the thyroid and the adrenal glands have been studied widely, still, little is known about the possible pathophysiological associations between thyroid autoimmunity and the occurrence of adrenal incidentalomas. This article presents a brief review of the common endocrine disorders with a special focus on the frequently coexisting insulin resistance and/or obesity. Furthermore, in response to the recent growing interest in endocrine disruptors, with their transgenerational epigenetic effects that influence hormonal system function, a concise overview of the topic has also been included.
format Online
Article
Text
id pubmed-10385892
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103858922023-07-30 A Brief Look at Hashimoto’s Disease, Adrenal Incidentalomas, Obesity and Insulin Resistance—Could Endocrine Disruptors Be the Other Side of the Same Coin? Gontarz-Nowak, Katarzyna Szklarz, Michał Szychlińska, Magdalena Matuszewski, Wojciech Bandurska-Stankiewicz, Elżbieta Medicina (Kaunas) Review Hashimoto’s disease (HD) is the most common cause of hypothyroidism in developed countries. The exact pathomechanism behind it has not been clearly established; however, an interplay of genetic susceptibility, environmental triggers (including diet) and epigenetic factors seems to be involved. Among the latter, increasingly more attention has been paid to some hormonally active substances, known as endocrine disruptors, which are commonly used worldwide. HD has become a condition widely reported in the media, acting as a culprit for inexplicable weight gain, chronic fatigue or weakness. Nevertheless, the recognition of HD is undeniably increasing and represents a major public health burden. At the same time, improving access to imaging tests has increased the number of incidentally diagnosed adrenal tumors. Above all, the widespread use of chest computed tomography (CT) due to the COVID-19 pandemic has contributed to frequent incidental detection of adrenal lesions. Fortunately, a vast majority of these findings are asymptomatic benign tumors with no excessive hormonal activity, and therefore, they are defined as adrenal incidentalomas (AIs). Interestingly, recent studies have indicated that patients with AIs are more prone to obesity and insulin resistance. Although mutual relationships between the thyroid and the adrenal glands have been studied widely, still, little is known about the possible pathophysiological associations between thyroid autoimmunity and the occurrence of adrenal incidentalomas. This article presents a brief review of the common endocrine disorders with a special focus on the frequently coexisting insulin resistance and/or obesity. Furthermore, in response to the recent growing interest in endocrine disruptors, with their transgenerational epigenetic effects that influence hormonal system function, a concise overview of the topic has also been included. MDPI 2023-06-30 /pmc/articles/PMC10385892/ /pubmed/37512046 http://dx.doi.org/10.3390/medicina59071234 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Gontarz-Nowak, Katarzyna
Szklarz, Michał
Szychlińska, Magdalena
Matuszewski, Wojciech
Bandurska-Stankiewicz, Elżbieta
A Brief Look at Hashimoto’s Disease, Adrenal Incidentalomas, Obesity and Insulin Resistance—Could Endocrine Disruptors Be the Other Side of the Same Coin?
title A Brief Look at Hashimoto’s Disease, Adrenal Incidentalomas, Obesity and Insulin Resistance—Could Endocrine Disruptors Be the Other Side of the Same Coin?
title_full A Brief Look at Hashimoto’s Disease, Adrenal Incidentalomas, Obesity and Insulin Resistance—Could Endocrine Disruptors Be the Other Side of the Same Coin?
title_fullStr A Brief Look at Hashimoto’s Disease, Adrenal Incidentalomas, Obesity and Insulin Resistance—Could Endocrine Disruptors Be the Other Side of the Same Coin?
title_full_unstemmed A Brief Look at Hashimoto’s Disease, Adrenal Incidentalomas, Obesity and Insulin Resistance—Could Endocrine Disruptors Be the Other Side of the Same Coin?
title_short A Brief Look at Hashimoto’s Disease, Adrenal Incidentalomas, Obesity and Insulin Resistance—Could Endocrine Disruptors Be the Other Side of the Same Coin?
title_sort brief look at hashimoto’s disease, adrenal incidentalomas, obesity and insulin resistance—could endocrine disruptors be the other side of the same coin?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385892/
https://www.ncbi.nlm.nih.gov/pubmed/37512046
http://dx.doi.org/10.3390/medicina59071234
work_keys_str_mv AT gontarznowakkatarzyna abrieflookathashimotosdiseaseadrenalincidentalomasobesityandinsulinresistancecouldendocrinedisruptorsbetheothersideofthesamecoin
AT szklarzmichał abrieflookathashimotosdiseaseadrenalincidentalomasobesityandinsulinresistancecouldendocrinedisruptorsbetheothersideofthesamecoin
AT szychlinskamagdalena abrieflookathashimotosdiseaseadrenalincidentalomasobesityandinsulinresistancecouldendocrinedisruptorsbetheothersideofthesamecoin
AT matuszewskiwojciech abrieflookathashimotosdiseaseadrenalincidentalomasobesityandinsulinresistancecouldendocrinedisruptorsbetheothersideofthesamecoin
AT bandurskastankiewiczelzbieta abrieflookathashimotosdiseaseadrenalincidentalomasobesityandinsulinresistancecouldendocrinedisruptorsbetheothersideofthesamecoin
AT gontarznowakkatarzyna brieflookathashimotosdiseaseadrenalincidentalomasobesityandinsulinresistancecouldendocrinedisruptorsbetheothersideofthesamecoin
AT szklarzmichał brieflookathashimotosdiseaseadrenalincidentalomasobesityandinsulinresistancecouldendocrinedisruptorsbetheothersideofthesamecoin
AT szychlinskamagdalena brieflookathashimotosdiseaseadrenalincidentalomasobesityandinsulinresistancecouldendocrinedisruptorsbetheothersideofthesamecoin
AT matuszewskiwojciech brieflookathashimotosdiseaseadrenalincidentalomasobesityandinsulinresistancecouldendocrinedisruptorsbetheothersideofthesamecoin
AT bandurskastankiewiczelzbieta brieflookathashimotosdiseaseadrenalincidentalomasobesityandinsulinresistancecouldendocrinedisruptorsbetheothersideofthesamecoin